Position
Chief Business Officer
Company
Ratio Therapeutics
BostonBiotechnologyHealth CareTherapeuticsPharmaceuticalDescription
Ratio Therapeutics Inc., an emerging pharmaceutical company specializing in radiopharmaceuticals for cancer treatment, announces the appointments of Bill Cupelo as the Chief Business Officer and D. Scott Holbrook, MS, FSNMMI-TS to its Board of Directors. These strategic additions to Ratio's leadership team will further advance Ratio's growth and innovation in the development and commercialization of radiopharmaceuticals for cancer diagnosis and treatment.
Quick answer
Ratio Therapeutics Inc. Appoints Bill Cupelo as Chief Business Officer (April 2, 2024). Ratio Therapeutics is based in Boston, Massachusetts, United States.
- Who is the new Chief Business Officer at Ratio Therapeutics?
- Ratio Therapeutics named Bill Cupelo Chief Business Officer, announced April 2, 2024.
- What did Ratio Therapeutics announce on April 2, 2024?
- Ratio Therapeutics Inc., an emerging pharmaceutical company specializing in radiopharmaceuticals for cancer treatment, announces the appointments of Bill Cupelo as the Chief Business Officer and D. Scott Holbrook, MS, FSNMMI-TS to its Board of Directors. These strategic additions to Ratio's leadership team will further advance Ratio's growth and innovation in the development and commercialization of...
- What does Ratio Therapeutics do?
- Ratio Therapeutics Inc. is a clinical-stage pharmaceutical company with the mission to accelerate the development of next-generation precision radiopharmaceuticals for solid tumors and transform oncology treatment...
- Where is Ratio Therapeutics based?
- Ratio Therapeutics is based in Boston, Massachusetts, United States.
- Which similar companies made leadership changes around the same time?
- Acadia Pharmaceuticals (April 2, 2024), Aculys Pharma (April 1, 2024), IDRx (March 27, 2024) and LeonaBio, Inc. (April 15, 2024) also announced leadership changes within 45 days of Ratio Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Pharmaceutical
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Acadia Pharmaceuticals Appoints Dr. Elizabeth H. Z. Thompson as Executive Vice President, Head of Research and Development (April 2, 2024)
- Aculys Pharma Appoints Hidemasa Tanigaki as Chief Executive Officer and Representative Director (April 1, 2024)
- IDRx Appoints Dr. David P. Kerstein as Chief Medical Officer (March 27, 2024)
- Athira Pharma Appoints Javier San Martin as Chief Medical Officer (April 15, 2024)
- Fulcrum Appoints Patrick Horn, M.D., Ph.D., as Chief Medical Officer (March 18, 2024)
- Oragenics Appoints Dr. James Kelly as Chief Medical Officer (March 18, 2024)
Who to call at Ratio Therapeutics, and when
A new leader at Ratio Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Ratio Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Ratio Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Ratio Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Ratio Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Ratio Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.